Pharma & Biopharma

Are you compliant with the new guidelines for elemental impurities? asks Sarah James

What is humanity? Sometimes it requires the vision to solve a problem that seems impossible

Thin layer chromatography and SERS track down Viagra in adulterated healthcare products

Carlo Bicchi is perfectly placed to reflect on the past, present and future of separation science

Ian Wilson on chemistry sets, big pharma, and why you should always hire people smarter than you

Is continuous, real-time analysis of biologics during manufacturing on its way?

We present nine application notes that highlight the versatility of mass spectrometry techniques.

How mass data is marching from R&D into more routine use: the search for genotoxic impurities

Size-exclusion chromatography – long a mainstay in routine biopharmaceutical analysis – receives an upgrade

Is two-dimensional liquid chromatography finally hitting the sweet spot for routine use?